⌘K
t
RTW Biotech Opportunities Ltd announced that non-executive director Nicola Blackwood purchased an aggregate of 23,373 ordinary shares. These shares were acquired via two transactions on the London Stock Exchange: 16,493 shares at $1.5585 on 6 October 2025, and 6,880 shares at $2.18844 on 23 December 2025.
| Date | 22 Jan 2026 |
| Time | 10:00:00 |
| Category | Director/PDMR dealings |
| ID | 9591P |
RTW BIOTECH OPPORTUNITIES LTD
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
The Company announces that Nicola Blackwood, non-executive director, purchased an aggregate of 23,373 shares in the fourth quarter of 2025. Due to an oversight these purchases were not notified to the Company and therefore not disclosed publicly. As soon as this oversight was identified the situation was rectified immediately Details of the purchases are set out below.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Nicola Blackwood
|
||||
|
2 |
Reason for the notification
|
|||||
|
a) |
Position/status
|
Director |
||||
|
b)
|
Initial notification /Amendment |
Initial notification
|
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a) |
Name |
RTW Biotech Opportunities Ltd |
||||
|
b) |
LEI |
549300Q7EXQQH6KF7Z84
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of no par value
GG00BKTRRM22 |
||||
|
b) |
Nature of the transaction |
Purchase of Shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
23,373
$1.7439
|
||||
|
e) |
Date of the transaction |
6 October 2025 and 23 December 2025
|
||||
|
f) |
Place of the transaction |
London Stock Exchange
|
||||